Home › Stocks › OBIO

Orchestra BioMed Holdings, Inc. (OBIO): insider buying, hedge funds & Congress trades

Orchestra BioMed Holdings, Inc. (OBIO): 15 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Jun 2, 2026Hochman David P
Director, Officer
5,000$3.83$19.1Kno history
Mar 16, 2026Hochman David P
Director, Officer
10,000$4.29$42.9Kno history
Nov 17, 2025Hochman David P
Director, Officer
5,000$4.07$20.4Kno history
Sep 19, 2025Aryeh Jason
Director
1,000$2.45$2.5Kno history
Aug 25, 2025Taylor Andrew Lawrence
Officer
2,000$2.55$5.1Kno history
Aug 25, 2025Hochman David P
Director, Officer
6,000$2.49$14.9Kno history
Aug 25, 2025Sherman Darren
Director, Officer
3,000$2.62$7.9Kno history
Aug 25, 2025Fain Eric S
Director
5,760$2.61$15.0Kno history
Aug 5, 2025Perceptive Life Sciences Master Fund Ltd
TenPercentOwner
700,000$2.75$1.9Mno history
Aug 4, 2025Hochman David P
Director, Officer
20,000$2.75$55.0Kno history
May 1, 2025Wong Roderick
TenPercentOwner
49,900$2.99$149.2Kno history
Apr 29, 2025Rtw Investments, Lp
TenPercentOwner
50,000$2.53$126.5Kno history
Dec 26, 2024Hochman David P
Director, Officer
4,000$4.66$18.6Kno history
Dec 20, 2024Taylor Andrew Lawrence
Officer
1,000$4.83$4.8Kno history
Dec 19, 2024Hochman David P
Director, Officer
5,000$4.91$24.6Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for OBIO

Free account. Know when insiders, famous funds or Congress trade it.

Start free